rs150785666

Variant summary

Our verdict is Benign. The variant received -10 ACMG points: 1P and 11B. PP2BP4_ModerateBP6BS1BS2

The NM_152296.5(ATP1A3):​c.1387C>T​(p.Arg463Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000647 in 1,614,084 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R463H) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.00048 ( 0 hom., cov: 31)
Exomes 𝑓: 0.00066 ( 2 hom. )

Consequence

ATP1A3
NM_152296.5 missense

Scores

4
8
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:7

Conservation

PhyloP100: 2.72

Publications

14 publications found
Variant links:
Genes affected
ATP1A3 (HGNC:801): (ATPase Na+/K+ transporting subunit alpha 3) The protein encoded by this gene belongs to the family of P-type cation transport ATPases, and to the subfamily of Na+/K+ -ATPases. Na+/K+ -ATPase is an integral membrane protein responsible for establishing and maintaining the electrochemical gradients of Na and K ions across the plasma membrane. These gradients are essential for osmoregulation, for sodium-coupled transport of a variety of organic and inorganic molecules, and for electrical excitability of nerve and muscle. This enzyme is composed of two subunits, a large catalytic subunit (alpha) and a smaller glycoprotein subunit (beta). The catalytic subunit of Na+/K+ -ATPase is encoded by multiple genes. This gene encodes an alpha 3 subunit. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
ATP1A3 Gene-Disease associations (from GenCC):
  • alternating hemiplegia of childhood 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Genomics England PanelApp, G2P
  • ATP1A3-associated neurological disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Genomics England PanelApp
  • developmental and epileptic encephalopathy 99
    Inheritance: AD Classification: STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • dystonia 12
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Genomics England PanelApp
  • encephalopathy, acute, infection-induced
    Inheritance: AD Classification: MODERATE Submitted by: Ambry Genetics
  • alternating hemiplegia of childhood
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • complex neurodevelopmental disorder
    Inheritance: AR Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -10 ACMG points.

PP2
Missense variant in the ATP1A3 gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 110 curated pathogenic missense variants (we use a threshold of 10). The gene has 22 curated benign missense variants. Gene score misZ: 6.3327 (above the threshold of 3.09). Trascript score misZ: 9.1232 (above the threshold of 3.09). GenCC associations: The gene is linked to alternating hemiplegia of childhood 2, developmental and epileptic encephalopathy 99, ATP1A3-associated neurological disorder, cerebellar ataxia-areflexia-pes cavus-optic atrophy-sensorineural hearing loss syndrome, dystonia 12, alternating hemiplegia of childhood, encephalopathy, acute, infection-induced, complex neurodevelopmental disorder.
BP4
Computational evidence support a benign effect (MetaRNN=0.20119265).
BP6
Variant 19-41981552-G-A is Benign according to our data. Variant chr19-41981552-G-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 377531.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00048 (73/152190) while in subpopulation NFE AF = 0.000808 (55/68038). AF 95% confidence interval is 0.000638. There are 0 homozygotes in GnomAd4. There are 39 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High Homozygotes in GnomAdExome4 at 2 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_152296.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A3
NM_152296.5
MANE Select
c.1387C>Tp.Arg463Cys
missense
Exon 11 of 23NP_689509.1P13637-1
ATP1A3
NM_001256214.2
c.1426C>Tp.Arg476Cys
missense
Exon 11 of 23NP_001243143.1P13637-3
ATP1A3
NM_001256213.2
c.1420C>Tp.Arg474Cys
missense
Exon 11 of 23NP_001243142.1P13637-2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP1A3
ENST00000648268.1
MANE Select
c.1387C>Tp.Arg463Cys
missense
Exon 11 of 23ENSP00000498113.1P13637-1
ENSG00000285505
ENST00000644613.1
n.1387C>T
non_coding_transcript_exon
Exon 11 of 25ENSP00000494711.1A0A2R8YEY8
ATP1A3
ENST00000545399.6
TSL:2
c.1426C>Tp.Arg476Cys
missense
Exon 11 of 23ENSP00000444688.1P13637-3

Frequencies

GnomAD3 genomes
AF:
0.000480
AC:
73
AN:
152190
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000327
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000207
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000808
Gnomad OTH
AF:
0.000956
GnomAD2 exomes
AF:
0.000465
AC:
117
AN:
251494
AF XY:
0.000419
show subpopulations
Gnomad AFR exome
AF:
0.000185
Gnomad AMR exome
AF:
0.000376
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000462
Gnomad NFE exome
AF:
0.000809
Gnomad OTH exome
AF:
0.000651
GnomAD4 exome
AF:
0.000664
AC:
971
AN:
1461894
Hom.:
2
Cov.:
32
AF XY:
0.000616
AC XY:
448
AN XY:
727248
show subpopulations
African (AFR)
AF:
0.000299
AC:
10
AN:
33480
American (AMR)
AF:
0.000380
AC:
17
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.000128
AC:
11
AN:
86258
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53420
Middle Eastern (MID)
AF:
0.000347
AC:
2
AN:
5768
European-Non Finnish (NFE)
AF:
0.000808
AC:
899
AN:
1112012
Other (OTH)
AF:
0.000513
AC:
31
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.465
Heterozygous variant carriers
0
65
131
196
262
327
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000480
AC:
73
AN:
152190
Hom.:
0
Cov.:
31
AF XY:
0.000525
AC XY:
39
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.000241
AC:
10
AN:
41446
American (AMR)
AF:
0.000327
AC:
5
AN:
15280
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5186
South Asian (SAS)
AF:
0.000207
AC:
1
AN:
4832
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10616
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.000808
AC:
55
AN:
68038
Other (OTH)
AF:
0.000956
AC:
2
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
4
8
12
16
20
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000603
Hom.:
0
Bravo
AF:
0.000465
TwinsUK
AF:
0.000539
AC:
2
ALSPAC
AF:
0.000778
AC:
3
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.000814
AC:
7
ExAC
AF:
0.000535
AC:
65
EpiCase
AF:
0.000709
EpiControl
AF:
0.00124

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
2
Dystonia 12 (3)
-
2
1
not specified (3)
-
1
1
not provided (2)
-
-
1
Alternating hemiplegia of childhood 2 (1)
-
-
1
ATP1A3-related disorder (1)
-
-
1
Inborn genetic diseases (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.33
BayesDel_addAF
Benign
-0.087
T
BayesDel_noAF
Uncertain
0.030
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Uncertain
0.75
D
Eigen
Uncertain
0.21
Eigen_PC
Benign
0.18
FATHMM_MKL
Benign
0.56
D
LIST_S2
Pathogenic
0.99
D
M_CAP
Uncertain
0.17
D
MetaRNN
Benign
0.20
T
MetaSVM
Uncertain
0.74
D
MutationAssessor
Benign
1.9
L
PhyloP100
2.7
PrimateAI
Uncertain
0.68
T
PROVEAN
Pathogenic
-4.9
D
REVEL
Uncertain
0.58
Sift
Pathogenic
0.0
D
Sift4G
Uncertain
0.010
D
Polyphen
0.68
P
Vest4
0.40
MVP
0.91
MPC
2.8
ClinPred
0.11
T
GERP RS
3.9
Varity_R
0.67
gMVP
0.92
Mutation Taster
=4/96
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs150785666; hg19: chr19-42485704; COSMIC: COSV57489265; COSMIC: COSV57489265; API